Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 10Carcinoma, Ovarian Epithelial 8Sarcoma 4Neurotoxicity Syndromes 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Testicular Neoplasms 3Breast Neoplasms 3Teratoma 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Germ Cell Cancer 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Hodgkin Disease 2Endometrial Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Wilms Tumor 1

Interventions

Vacuum Curettage 2Drug Therapy 2Pemetrexed 1Methotrexate 1Letrozole 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hydatidiform Mole × Amifostine × Gynecologic × Clear all
NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

GOG Foundation

Phase 3 Completed
100 enrolled
Gynecologic

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡